2nd Quarter - Report
PRIME POLICY GROUP for VERAX BIOMEDICAL, INC.
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Blood Safety; FDA Draft Guidance re: Bacterial Detection by Blood Collection Establishments & Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARY GIBSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.